Biological pathways to bladder carcinogenesis

M. L. Gonzalgo, M. P. Schoenberg, R. Rodriguez

Research output: Contribution to journalArticle

Abstract

The transformation of normal urothelium into histologically different neoplastic states has been well characterized, and current clinical management of both superficial and invasive bladder cancer has benefited from recent scientific discoveries. The ability to define novel treatment strategies including surgical, chemotherapeutic, and gene therapies relies on our understanding of the basic mechanisms underlying human bladder carcinogenesis. Many in vitro culture systems and in vivo animal models have been developed over recent years, which have been used to define key molecular events that are associated with the development of bladder cancer. The biological pathways through which normal urothelium may progress to superficial or invasive disease will be discussed in the framework of recent advances in the field. Copyright (C) 2000 by W.B. Saunders Company.

Original languageEnglish (US)
Pages (from-to)256-263
Number of pages8
JournalSeminars in Urologic Oncology
Volume18
Issue number4
StatePublished - 2000

Fingerprint

Urothelium
Urinary Bladder Neoplasms
Carcinogenesis
Urinary Bladder
Genetic Therapy
Animal Models
Therapeutics
In Vitro Techniques

Keywords

  • Adenovirus
  • BCG
  • Bladder cancer
  • CAR
  • Gene therapy
  • Urology

ASJC Scopus subject areas

  • Urology

Cite this

Gonzalgo, M. L., Schoenberg, M. P., & Rodriguez, R. (2000). Biological pathways to bladder carcinogenesis. Seminars in Urologic Oncology, 18(4), 256-263.

Biological pathways to bladder carcinogenesis. / Gonzalgo, M. L.; Schoenberg, M. P.; Rodriguez, R.

In: Seminars in Urologic Oncology, Vol. 18, No. 4, 2000, p. 256-263.

Research output: Contribution to journalArticle

Gonzalgo, ML, Schoenberg, MP & Rodriguez, R 2000, 'Biological pathways to bladder carcinogenesis', Seminars in Urologic Oncology, vol. 18, no. 4, pp. 256-263.
Gonzalgo ML, Schoenberg MP, Rodriguez R. Biological pathways to bladder carcinogenesis. Seminars in Urologic Oncology. 2000;18(4):256-263.
Gonzalgo, M. L. ; Schoenberg, M. P. ; Rodriguez, R. / Biological pathways to bladder carcinogenesis. In: Seminars in Urologic Oncology. 2000 ; Vol. 18, No. 4. pp. 256-263.
@article{6d118c2cc9da4b38a31f1125316bcf33,
title = "Biological pathways to bladder carcinogenesis",
abstract = "The transformation of normal urothelium into histologically different neoplastic states has been well characterized, and current clinical management of both superficial and invasive bladder cancer has benefited from recent scientific discoveries. The ability to define novel treatment strategies including surgical, chemotherapeutic, and gene therapies relies on our understanding of the basic mechanisms underlying human bladder carcinogenesis. Many in vitro culture systems and in vivo animal models have been developed over recent years, which have been used to define key molecular events that are associated with the development of bladder cancer. The biological pathways through which normal urothelium may progress to superficial or invasive disease will be discussed in the framework of recent advances in the field. Copyright (C) 2000 by W.B. Saunders Company.",
keywords = "Adenovirus, BCG, Bladder cancer, CAR, Gene therapy, Urology",
author = "Gonzalgo, {M. L.} and Schoenberg, {M. P.} and R. Rodriguez",
year = "2000",
language = "English (US)",
volume = "18",
pages = "256--263",
journal = "Urologic Oncology",
issn = "1078-1439",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Biological pathways to bladder carcinogenesis

AU - Gonzalgo, M. L.

AU - Schoenberg, M. P.

AU - Rodriguez, R.

PY - 2000

Y1 - 2000

N2 - The transformation of normal urothelium into histologically different neoplastic states has been well characterized, and current clinical management of both superficial and invasive bladder cancer has benefited from recent scientific discoveries. The ability to define novel treatment strategies including surgical, chemotherapeutic, and gene therapies relies on our understanding of the basic mechanisms underlying human bladder carcinogenesis. Many in vitro culture systems and in vivo animal models have been developed over recent years, which have been used to define key molecular events that are associated with the development of bladder cancer. The biological pathways through which normal urothelium may progress to superficial or invasive disease will be discussed in the framework of recent advances in the field. Copyright (C) 2000 by W.B. Saunders Company.

AB - The transformation of normal urothelium into histologically different neoplastic states has been well characterized, and current clinical management of both superficial and invasive bladder cancer has benefited from recent scientific discoveries. The ability to define novel treatment strategies including surgical, chemotherapeutic, and gene therapies relies on our understanding of the basic mechanisms underlying human bladder carcinogenesis. Many in vitro culture systems and in vivo animal models have been developed over recent years, which have been used to define key molecular events that are associated with the development of bladder cancer. The biological pathways through which normal urothelium may progress to superficial or invasive disease will be discussed in the framework of recent advances in the field. Copyright (C) 2000 by W.B. Saunders Company.

KW - Adenovirus

KW - BCG

KW - Bladder cancer

KW - CAR

KW - Gene therapy

KW - Urology

UR - http://www.scopus.com/inward/record.url?scp=0033678824&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033678824&partnerID=8YFLogxK

M3 - Article

C2 - 11101088

AN - SCOPUS:0033678824

VL - 18

SP - 256

EP - 263

JO - Urologic Oncology

JF - Urologic Oncology

SN - 1078-1439

IS - 4

ER -